Surgical Management of Desmoid Tumors—Patient Selection, Timing, and Approach
Open Access
- 18 July 2025
- journal article
- review article
- Published by MDPI AG in Current Oncology
- Vol. 32 (7) , 408
Abstract
Desmoid tumors are rare, deep-seated myofibroblastic tumors with an unpredictable course, ranging from spontaneous regression to infiltrative growth and locally aggressive behavior, but without metastatic potential. Over the past few decades, advances in understanding their natural history, underlying molecular pathways, and patient care priorities have shifted the treatment paradigm from upfront surgical resection to initial active surveillance, with further treatment dictated by continuous disease progression or associated symptoms. However, there are still specific scenarios where surgery continues to play an important role in locoregional treatment and symptom control. This article will focus on current treatment strategies and surgical indications in adult patients with desmoid tumors, emphasizing patient selection, anatomic site-specific considerations, and surgical technique. Understanding the nuanced role of surgery within the growing treatment landscape is key for individualized patient care in a multidisciplinary setting to optimize quality of life and long-term outcomes.Keywords
This publication has 73 references indexed in Scilit:
- Current Management of Desmoid TumorsJAMA Oncology, 2024
- Pain in desmoid‐type fibromatosis: Prevalence, determinants and prognosis valueInternational Journal of Cancer, 2023
- Management of serious complications in intra‐abdominal desmoid‐type fibromatosisCancer Reports, 2021
- Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosisBritish Journal of Surgery, 2017
- Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid‐type fibromatosis by whole‐exome sequencing and genomic analysisGenes, Chromosomes and Cancer, 2015
- Isolated limb perfusion using tumour necrosis factor α and melphalan in patients with advanced aggressive fibromatosisBritish Journal of Surgery, 2014
- Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposisBritish Journal of Surgery, 2014
- Surgical resection for non-familial adenomatous polyposis-related intra-abdominal fibromatosisBritish Journal of Surgery, 2012
- Multimodality management of desmoid tumors: How important is a negative surgical margin?Journal of Surgical Oncology, 2008
- A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposisBritish Journal of Surgery, 2006